PMI’s FDA-approved SynCardia STAH is promising, but adoption and revenues lag; cash burn and dilution weigh. Read the full ...
January 2026 EverQuest Capital Partners is pleased to announce the launch of EverQuest EIS Fund II, a UK Enterprise ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback